Relearning How to Move: The Research, Devices and Infrastructure Reshaping Mobility Rehabilitation

A brain implant that lets a paralysed person feel their own footsteps again, a small NHS hospital building its own robotic arm because nothing on the market quite fits and a £105 million national centre in Nottinghamshire about to open its doors. Mobility rehabilitation is advancing on three fronts at once, from the neuroscience lab to the physiotherapy gym to the building site.

Restoring the ability to walk, reach or grip after a spinal cord injury, stroke or serious trauma has always sat at an awkward intersection of neuroscience, robotics and healthcare delivery. A breakthrough in one area rarely means much without progress in the other two. A brain-computer interface is only useful if there is a device for it to control. A robotic exoskeleton only helps a patient if a clinician has the facility and the time to use it properly. What is notable about 2026 is that meaningful progress is turning up at every level of that chain, from fundamental neuroscience through to bricks and mortar.

Teaching an Exoskeleton to Feel

The most striking development sits at the research end. In April, a team led by researchers at UC Irvine, working with Caltech and the University of Southern California’s Keck School of Medicine, published results in the journal Brain Stimulation describing the first bidirectional brain-computer interface to control a walking exoskeleton while also feeding artificial sensation back to the user. Existing robotic gait exoskeletons rely on manual control and give the wearer no sense of the ground beneath their feet, a gap known to slow walking speed and increase the risk of falls.

The team’s system decodes movement intent from electrical signals recorded on the leg motor cortex and, at the same time, delivers artificial leg sensation through targeted electrical stimulation of the somatosensory cortex, creating what the researchers describe as a closed loop, brain-driven experience of walking. A single participant, a 50-year-old woman already undergoing brain monitoring for epilepsy, operated the system across ten exercises and correctly identified steps in a blind counting task with almost 93% accuracy. She reported that the sensory feedback genuinely helped her control the exoskeleton. Dr An Do of UC Irvine, one of the study’s co-authors, said the work “demonstrates that it’s feasible to restore both the motor and sensory dimensions of walking using a single, compact, embedded brain-computer interface system,” and that the team now sees it as a foundation for a fully implantable version. The entire system currently runs on a portable embedded platform rather than a tethered computer, which the researchers say is essential if anything like it is ever to be used outside a lab. The project was funded by the US National Science Foundation.

A Hospital Builds Its Own Device

Move from a California neuroscience lab to a specialist orthopaedic hospital in Shropshire and the scale changes considerably, but the underlying problem, that existing commercial technology does not always fit real patients, is much the same. The Robert Jones and Agnes Hunt Orthopaedic Hospital (RJAH) announced this month that a new phase of clinical work is beginning on ExoARM, a lightweight robotic device designed to help patients regain arm and hand function after neurological or musculoskeletal injury, using myoelectric technology to make intensive rehabilitation more consistent and engaging.

The project grew directly out of an earlier pilot at RJAH using a commercial upper-limb exoskeleton, which exposed gaps that led the hospital’s own team to develop something more clinically responsive and affordable. Funding for the next stage, £30,000 from the hospital’s League of Friends matched by a further £30,000 contributed personally by Dr Heba Lakany, the device’s inventor and an academic specialising in myoelectric control systems, will take the current prototype to a clinically usable device, build two functional units and run a small usability study with five to seven patients. Mr Simon Pickard, the consultant orthopaedic hand and upper limb surgeon leading the clinical side of the project, said the work would position RJAH “at the forefront of assistive technology development, influencing future device design, clinical pathways and standards of care across the NHS.” It is a modest budget next to a multimillion-pound research grant, but it captures something important about where rehabilitation technology often actually gets built: inside the hospitals treating the patients who need it, funded in part by local charity.

The Building Where It All Comes Together

The third piece of the picture is infrastructure, and it is considerably larger in scale. Nottingham University Hospitals NHS Trust took delivery of the keys to the country’s first NHS National Rehabilitation Centre (NRC) in late July, with the first patients due to move in during the first week of September. The centre had originally been due to open on 11 November 2025, but a failed water quality check, ultimately requiring 183 mixer taps to be replaced and a chlorine dioxide unit installed, pushed the opening back by roughly ten months.

The £105 million NRC, funded through the government’s New Hospital Programme, is a 70-bed facility on the Stanford Hall Rehabilitation Estate near Loughborough, co-located with the Defence Medical Rehabilitation Centre so the two can share specialist facilities including a hydrotherapy suite, an advanced gait laboratory and a 360-degree immersive virtual reality environment. NUH describes it as home to the most comprehensive robotics suite in the NHS, including devices to help patients walk again, relearn hand function and rebuild strength in specific muscle groups, alongside the first 360-degree hoist in Europe, installed in the main gym to let patients practise walking and moving in a more realistic way than a standard treadmill allows. It is also the NHS’s first operationally carbon neutral building, powered by rooftop solar and air source heat pumps. Anthony May, NUH’s Chief Executive, called it the result of “15 years in the making,” while NRC Director Miriam Duffy described the opening as “just the beginning” of an effort to make intensive, timely rehabilitation available to every NHS patient who needs it, not only those near a specialist centre. The long-term ambition, according to NUH, is for the NRC to act as the national hub in a future hub-and-spoke model, with regional units eventually extending its reach across the country.

Why the Sequencing Matters

None of these three developments alone would count as transformative. A single-patient proof of concept in a neuroscience journal, a five-to-seven patient usability study funded by a hospital charity and a newly opened building are each, in isolation, early steps rather than finished solutions. What makes 2026 a genuinely useful moment to take stock is that they represent three necessary links in the same chain, arriving in roughly the same window. The UC Irvine study points to where implantable neurotechnology for walking is heading over the next decade. The RJAH project shows how that kind of innovation gets translated into something a physiotherapist can actually put on a patient tomorrow, often through unglamorous, locally funded, clinician-led development rather than a venture-backed spin-out. And the National Rehabilitation Centre demonstrates what it takes, in capital, coordination and years of planning, to give any of this technology somewhere proper to be used at scale.

Rehabilitation technology has a long history of impressive demonstrations that never quite reach the patients who could benefit from them, usually because the gap between laboratory result and everyday clinical practice is treated as someone else’s problem to solve. The most encouraging thing about this year’s crop of developments is that each one is explicitly aimed at closing that gap rather than widening the space between what is scientifically possible and what a patient can actually access.

Sources include the University of California, Brain Stimulation, Digital Health Technology News UK, Nottingham University Hospitals NHS Trust and the Institute of Healthcare Engineering and Estate Management.

Author

Leave A Comment

Graham Combe

Strategic Consultant,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Graham Combe is an experienced strategic consultant, relationship builder, and entrepreneur in the global life sciences sector. He holds a BSc (Hons) in Chemistry from University College London (UCL) and spent over a decade with Nature, where he pioneered key initiatives such as Nature’s BioPharma Dealmakers and Nature’s SciCafe.

In May 2011, he founded Biosell UK, a consulting and event management firm that collaborates with global life science publishers, event organizations, and marketing partners. Beyond BioSell, Combe is the founder or co-founder of several prominent networking and thought-leadership platforms, including #BiotechBuddies, #coffeebuddies, the #AgileLeaders Forum, and the Creative Disruption Forum—the latter three events co-hosted with his business partner, Professor Tony Sedgwick.

Specializing in the early-to-mid stages of drug development (from pre-clinical research through Phase 3 and clinical proof-of-concept), Graham focuses on facilitating forums to promote peer-to-peer discussion, strategic growth, investment and meaningful connections between biotech innovators, investors, and industry service providers.

Secure your Launch Day Conference Pass

Be in the room where the future of life sciences is shaped.

Early Bird until 31 August: Save £155

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details